论文信息 - Abstract CT178: Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study - 字舞流文

Abstract CT178: Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD): Initial results of the phase 2 KEYLYNK-007 study

H. Gómez | R. Cristescu | T. Ciuleanu | M. Maio | S. Im | T. Yap | M. Schenker | I. Lugowska | R. Shapira-Frommer | A. Hill | S. Saraf | F. Jin | O. Ozyılkan | S. Stemmer | K. Vera | M. Quintela-Fandino | A. Kryzhanivska | A. Gozman | Serhii Lysenko